Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
34.49
+0.06 (0.17%)
At close: Dec 31, 2025, 4:00 PM EST
34.80
+0.31 (0.90%)
After-hours: Dec 31, 2025, 7:57 PM EST
Liquidia Market Cap
Liquidia has a market cap or net worth of $3 billion as of December 31, 2025. Its market cap has increased by 224.65% in one year.
Market Cap
3.00B
Enterprise Value
3.04B
1-Year Change
224.65%
Ranking
Category
Stock Price
$34.49
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $3.00B, an increase of 1,688.40%. That is a compound annual growth rate of 47.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.00B | 201.46% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |